Searched for
CAPITAL INJECTIONS
Global Market: China insurer recapitalisation may ease capital constraints and support stock investmentsChina’s planned $53.6 billion recapitalisation of state-owned insurers and banks could ease solvency pressures and strengthen insurers’ cap...- Global Market: China stocks range-bound as tech gains offset bank, insurance sector lossesChinese stocks were largely range-bound on Monday as gains in technology shares offset losses in banks and insurers following Beijing’s $54...
- Axis Direct initiates coverage on Pricol with Buy rating. Check target pricePricol shares gained after Axis Direct initiated coverage with a Buy rating and a Rs 935 target price, implying around 21% upside. The brok...
- China to pump $54 billion into state banks, insurers in capital-boosting pushChina's finance ministry is injecting over fifty billion dollars into state-owned financial institutions. This coordinated push aims to str...
- Which stocks should you buy ahead of the festive season? Here are Kotak Securities’ top 10 picksIndia’s festive season is expected to drive a strong consumption boost, with analysts identifying sectors and stocks that could benefit. Th...
- Tata Sons readies fresh ₹10,000 crore bet on Air India as losses mount, but T&C applyTata Sons' board approved over Rs 10,000 crore for Air India's capital infusion. This significant funding is contingent upon business cases...
- Iran defiant as Scott Bessent says US likely to announce bank sanctions this weekWashington plans to announce bank sanctions against Iran this week. Oil prices increased after direct attacks and tanker incidents. Iran wa...
- Hy-Tech Engineers shares make strong D-Street debut, list at 42% premium over IPO priceThe Rs 135.73-crore IPO was offered at a price of Rs 53 per share. The issue comprised a fresh issue of 1.13 crore shares worth Rs 60 crore...
- GST Council to hold 57th meet on Sept 12 with ITC, simplifying the GST corporate guarantees & more on agendaThe GST Council will meet on September 12 to discuss key reforms. Proposals include easier input tax credit access for buyers and simplifie...
- Hy-Tech Engineers IPO Day 4: GMP signals 83% premium, subscription hits 50.86xThe final day of bidding for the Hy-Tech Engineers IPO has arrived, showcasing strong investor enthusiasm. Retail participation has surged,...
- Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31xSymbiotec Pharmalab's IPO saw strong investor demand, closing oversubscribed 71.26 times. The company aimed to raise Rs 1,757 crore through...
- Sembcorp Green Infra files for $393 million India IPOSembcorp Green Infra has announced its intention to launch an initial public offering in Mumbai, aiming to gather as much as 37.5 billion r...
- Air India’s $1.5 billion funding ask sparks backlash in Singapore parliamentA Singapore politician questions the logic of Singapore Airlines supporting Air India. He opposes using Temasek funds for Air India's turna...
- Hy-Tech Engineers IPO Day 2: GMP soars 57%, subscription reaches 7.74x. Should you subscribe?Hy-Tech Engineers IPO experienced robust demand on its second day. The overall issue was subscribed 19.31 times against shares offered. Gre...
- Hy-Tech Engineers IPO Day 3: GMP at 57%, Issue subscribed 51 timesThe Hy-Tech Engineers IPO entered its third day of bidding on August 26, with the issue subscribed 51 times by the end of Day 3. Retail inv...
- Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?Symbiotec Pharmalab's IPO saw robust investor demand, with the issue subscribed 1.85 times. The company aims to raise Rs 1,757 crore throug...
- Symbiotec Pharmalab’s Rs 1,757 crore IPO opens with GMP hinting at 41% upside. Should you bid?Symbiotec Pharmalab IPO GMP: Symbiotec Pharmalab’s Rs 1,757 crore IPO opened August 24, with a Rs 938–988 price band and 41% grey-market pr...
- Hy-Tech Engineers IPO opens today: GMP signals 47% listing premium. Should you subscribe?Hy-Tech Engineers IPO: The Rs 135.73-crore issue set to remain open until August 27. The IPO comprises a fresh issue of Rs 60 crore and an ...
- Can Symbiotec Pharmalab IPO deliver long-term growth for high-risk investors?Symbiotec Pharmalab plans a ₹150 crore IPO to repay debt and expand operations. The company holds a global leadership position in corticost...
- State can't take life arbitrarily or without dignity: Supreme CourtThe Supreme Court ruled that state execution powers are not arbitrary. The method of execution must uphold human dignity and minimize suffe...
Load More
